
Bylenta MLN 10mg/50mg/40mg Tablet
Marketer
Lloyd Healthcare Pvt Ltd
Salt Composition
Cilnidipine (10mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg)
Overview Bylenta MLN 10mg/50mg/40mg Tablet
Tribenza HT 10mg/50mg/40mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of stroke and heart attack. Tribenza HT can be taken with food at any time, but consistent daily timing is recommended. Continue treatment as prescribed; discontinuing, even feeling well, may worsen hypertension, which often presents asymptomatically. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, are beneficial adjuncts. Closely follow your physician's instructions. Potential side effects include nausea, altered taste, pharyngitis, backache, and edema. Elevating your legs can alleviate swelling. Avoid potassium-rich foods and supplements. Regular monitoring of blood pressure, renal function, glycemia, and electrolytes may be necessary. Inform your doctor of any pre-existing liver or kidney conditions before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Always disclose all current medications, especially those for hypertension or cardiac conditions.
Primary Ingredients of Bylenta MLN 10mg/50mg/40mg Tablet
No text provided to rephrase.
Uses of Bylenta MLN 10mg/50mg/40mg Tablet
Elevated arterial blood pressure
Major Benefits of Bylenta MLN 10mg/50mg/40mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Bylenta MLN 10mg/50mg/40mg tablets with food.
Common Side effects of Bylenta MLN 10mg/50mg/40mg Tablet:
- Nausea
- Taste change
- Diarrhea
- Headache
- Dizziness
- Weakness
- Ankle swelling
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Edema (swelling)
- Slow heart rate
- Cold extremities
- Decreased blood pressure
- Throat infection
How to use Bylenta MLN 10mg/50mg/40mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Bylenta MLN 10mg/50mg/40mg Tablet with food.
How Bylenta MLN 10mg/50mg/40mg Tablet works:
Each Bylenta tablet (10mg/50mg/40mg) combines three distinct medications.
SAFETY ADVICE
AlcoholUNSAFE
Combining Bylenta MLN 10mg/50mg/40mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Bylenta MLN 10mg/50mg/40mg Tablet is contraindicated in pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Bylenta MLN 10mg/50mg/40mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Bylenta MLN 10mg/50mg/40mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Bylenta MLN 10mg/50mg/40mg Tablet use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Bylenta MLN 10mg/50mg/40mg tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates the use of Bylenta MLN 10mg/50mg/40mg tablets; consult a physician for guidance.
What if you forget to take Bylenta MLN 10mg/50mg/40mg Tablet :
Should you forget to take a Bylenta MLN 10mg/50mg/40mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bylenta MLN 10mg/50mg/40mg Tablet
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | HEART |